Clinical trial Recruiting at 1 site Interventional

Focusing ultrasound to the central thalamus to help people with disorders of consciousness

Official title: Assessment of Safety and Feasibility of FUS Next Generation Dome Helmet (NGDH) to Perform Neuromodulation in Patients With Disorders of Consciousness

Run by Sunnybrook Health Sciences Centre · NCT07694258 · Data updated 2026-11-12

This study tests whether two sessions of low-intensity focused ultrasound can safely help people with severe brain injuries see if they become more awake or responsive.

More Disorders of Consciousness trials

Quick facts

Study typeInterventional
SexAll
Enrollment10 (estimated)
SponsorSunnybrook Health Sciences Centre
Academic / other
Locations1 site (Toronto, Ontario)
StatusRecruiting
StartedSeptember 10, 2025
Main results expectedSeptember 2027
Study endsSeptember 2028
Registry record updatedJuly 9, 2026
Trial IDNCT07694258 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with severe traumatic or non-traumatic brain injury and persistent impaired consciousness (CRS-R/GCS below certain thresholds), without contraindicating medical conditions, eligible ICP, and safety for MRI.

Probably not a fit

Patients with ongoing seizures, active post-anoxic myoclonus, or those outside the defined ICP/safety criteria may not benefit and could be at risk.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a small, single-center pilot study that will apply two sessions of low-intensity FUS neuromodulation to the bilateral central thalamus, about four weeks apart, in people with disorders of consciousness. Participants will have extensive safety monitoring and undergo imaging, EEG, and standardized scales before and after treatment to look for short-term changes in arousal and brain activity. The study also collects follow-up data up to 12 months when feasible to assess longer-term effects. The approach uses the Next Generation Dome Helmet to deliver targeted ultrasound while patients are monitored for safety. Results will inform feasibility, safety, and potential signals of clinical or neurophysiological change.

Why it matters

Potential benefit: If successful, the approach could offer a noninvasive option to potentially enhance arousal and responsiveness in some patients with disorders of consciousness.

How similar studies have gone: Previous work in similar neuromodulation approaches has shown safety signals in related brain stimulation methods, but this exact FUS protocol for DoC is exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Diagnosis of severe traumatic brain injury, hypoxic-ischemic brain injury, or other acute brain injury.
2. Glasgow coma scale below 13 when off sedation, or on minimal sedation.
3. Absence of another better explanation for the depressed level of consciousness (e.g,, metabolic abnormality, seizures)
4. Intracranial pressure (ICP) is within a normal range (\< 20 cm H2O), or, a neurosurgeon associated with the study and/or the treating physician agree that ICP is likely \< 20 cm H2O based on clinical and neuroimaging information (acknowledging the limitations of non-invasive assessment of ICP53).
5. The treating physician and/or neurosurgeon associated with the study evaluate it to be safe for the patient to be transported to the MRI scanner for a \~45 minute scan.

Exclusion Criteria:

1. Active seizure activity or post-anoxic myoclonus at the time of proposed treatment
2. Taking full anti-coagulation medication (does not include deep-vein-thrombosis chemoprophylaxis)
3. Skull anatomy incompatible with safe FUS delivery (as determined by CT)
4. Medical instability that would preclude safe transport or prolonged supine positioning
5. Presence of any MRI-incompatible implants or devices

Where it's running

  • Sunnybrook Health Sciences Centre
    Toronto, Ontario, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.